By applying a hybrid capture targeted sequencing approach, we not only systematically profile SNVs along the RB1 gene, but we also observe high intra-patient concordance of SCNAs between respective AH and tumor samples (Figure 1) and confirm all germline RB1 variants in each bioanalyte. Here, RB1 is linked to neoplasm.